Sintenovo Sa De Cv, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PALIPERIDONE, with a corresponding US DMF Number 26254.
Remarkably, this DMF maintains an Active status since its submission on July 27, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 13, 2014, and payment made on January 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II